module 203.1 en_0

32
PHARMACOLOGICAL MANAGEMENT BLOOD GLUCOSE-LOWERING MEDICINES

Upload: diabetes-for-all

Post on 11-Apr-2017

50 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: Module 203.1 en_0

PHARMACOLOGICAL MANAGEMENTBLOOD GLUCOSE-LOWERING MEDICINES

Page 2: Module 203.1 en_0

Objectives

Page 3: Module 203.1 en_0

Aims of treatment

Page 4: Module 203.1 en_0

UKPDS: long-term glucose control

Page 5: Module 203.1 en_0

Natural history of type 2 diabetes

Page 6: Module 203.1 en_0

Mechanism of action

Page 7: Module 203.1 en_0

Biguanides

Page 8: Module 203.1 en_0

Biguanides

Page 9: Module 203.1 en_0

Sulphonylureas & Meglitinides

Page 10: Module 203.1 en_0

Sulphonylureas

Page 11: Module 203.1 en_0

Thiazolidinediones

Page 12: Module 203.1 en_0

Alpha-glucosidase inhibitors

Page 13: Module 203.1 en_0

GLP-1 (Incretin Mimetic Agent)

Page 14: Module 203.1 en_0

DPP- 4 inhibitors

Page 15: Module 203.1 en_0

Action of GLP-1 & DPP-4 inhibitors

Page 16: Module 203.1 en_0

Understanding the names

Page 17: Module 203.1 en_0

Activity

Page 18: Module 203.1 en_0

The principles of combination therapy

Page 19: Module 203.1 en_0

Expected effect of glucose-lowering medicines

Page 20: Module 203.1 en_0

Adherence rates

Page 21: Module 203.1 en_0

Strategies to help people remember

Page 22: Module 203.1 en_0

Activity

Page 23: Module 203.1 en_0

Blood glucose targets

Page 24: Module 203.1 en_0

Suggested starting medicine (1 of 2)

Page 25: Module 203.1 en_0

Suggested starting medicine (2 of 2)

Page 26: Module 203.1 en_0

Increasing or adding

Page 27: Module 203.1 en_0

Older people with diabetes

Page 28: Module 203.1 en_0

Older people with diabetes

Page 29: Module 203.1 en_0

Activity

Page 30: Module 203.1 en_0

Case study

Page 31: Module 203.1 en_0

Summary

Page 32: Module 203.1 en_0

References